SEARCH

SEARCH BY CITATION

References

  • Almeida L, Minciu I, Nunes T, Butoianu N, Falcao A, Magureanu SA, Soares-da-Silva P. (2008a) Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy. J Clin Pharmacol48:966977.
  • Almeida L, Potgieter JH, Maia J, Potgieter MA, Mota F, Soares-da-Silva P. (2008b) Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol64:267273.
  • Almeida L, Bialer M, Soares-da-Silva P. (2009) Eslicarbazepine acetate. In Shorvon S, Perucca E, Engel J (Eds) The treatment of epilepsy. Blackwell Publishing, Oxford, pp. 485498.
  • Almeida L, Nunes T, Sicard E, Rocha JF, Falcao A, Brunet JS, Lefebvre M, Soares-da-Silva P. (2010) Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects. Acta Neurol Scand121:257264.
  • Ambrosio AF, Soares-da-Silva P, Carvalho CM, Carvalho AP. (2002) Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res27:121130.
  • Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y, Moore A, Flesch G, Kramer L, D’Souza J. (2000) Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia41:15971607.
  • Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P. (1999) Anticonvulsant and sodium channel-blocking properties of novel 10,11- dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J Med Chem42:25822587.
  • Ben-Menachem E, Gabbai AA, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P. (2010) Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res89:278285.
  • Bialer M, Soares-da-Silva P. (2012) Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia53:935946.
  • Bonifacio MJ, Sheridan RD, Parada A, Cunha RA, Patmore L, Soares-da-Silva P. (2001) Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine. Epilepsia42:600608.
  • Bonifacio MJ, Bulling A, Hebeisen S, Konrad D, Soares-da-Silva P. (2011) Eslicarbazepine and R-licarbazepine do not have effects on ion transmission through alpha1, alpha2, alpha3 and alpha5 GABA channels. Epilepsia52(Suppl. 6):258.
  • Brady K, Hebeisen S, Konrad D, Soares-da-Silva P. (2011) The effects of eslicarbazepine, R-licarbazepine, oxcarbazepine and carbamazepine on ion transmission Cav3.2 channels. Epilepsia52(Suppl. 6):260.
  • Brodie MJ, Kwan P. (2005) Epilepsy in elderly people. Br Med J331:13171322.
  • Brodie MJ, Yuen AW. (1997) Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res26:423432.
  • Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P. (2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia48:497504.
  • Elger C, Halasz P, Maia J, Almeida L, Soares-da-Silva P. (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia50:454463.
  • Falcao A, Maia J, Almeida L, Mazur D, Gellert M, Soares-da-Silva P. (2007) Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker. Biopharm Drug Dispos28:249256.
  • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. (2004) Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia45:410423.
  • Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P. (2009) Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand120:281287.
  • Hainzl D, Parada A, Soares-da-Silva P. (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(−)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res44:197206.
  • Hebeisen S, Brady K, Konrad D, Soares-da-Silva P. (2011) Inhibitory effects of eslicarbazepine acetate and its metabolites against neuronal voltage-gated sodium channels. Epilepsia52:257258.
  • Maia J, Almeida L, Falcão A, Soares E, Mota F, Potgieter JH, Potgieter MA, Soares-da-Silva P. (2008) Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate. Int J Clin Pharmacol Ther46:119130.
  • Perucca E. (2009) General principles of medical management. In Shorvon S, Perucca E, Engel J (Eds) The treatment of epilepsy. Blackwell Publishing, Oxford, pp. 121139.
  • Perucca E, Elger C, Halasz P, Falcao A, Almeida L, Soares-da-Silva P. (2011) Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures. Epilepsy Res96:132139.
  • Pires N, Palma N, Loureiro AI, Bonifacio MJ, Wright LC, Soares-da-Silva P. (2011) Effects of eslicarbazepine acetate, eslicarbazepine, carbamazepine and oxcarbazepine in the maximal electroconvulsive test in the mice. Epilepsia52(Suppl. 6):118.
  • Reife R, Pledger G, Wu SC. (2000) Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia41(Suppl. 1):S66S71.
  • Rowland A, Elliot DJ, Williams JA, Mackenzie PI, Dickinson RG, Miners JO. (2006) In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction. Drug Metab Dispos34:10551062.
  • Sillanpaa M, Haataja L, Tomson T, Johannessen SI. (2009) Carbamazepine. In Shorvon S, Perucca E, Engel J (Eds) The treatment of epilepsy. Blackwell Publishing, Oxford, pp. 459474.
  • Soares-da-Silva P, Bulling A, Hebeisen S, Konrad D. (2011) The effects of eslicarbazepine, R-licarbazepine and carbamazepine on ion transmission through Kv7.2 channels. Epilepsia52:258259.
  • Torrao L, Machado R, Pires N, Palma N, Bonifacio MJ, Wright LC, Soares-da-Silva P. (2011) The effects of eslicarbazepine acetate, eslicarbazepine, carbamazepine and oxcarbazepine in the 6-Hz psychomotor seizure model in the mice. Epilepsia52:118119.
  • Walker C, Surges R, Fisher A. (2009) Mechanisms of antiepileptic drug action. In Shorvon S, Perucca E, Engel J (Eds) The treatment of epilepsy. Blackwell Publishing, Oxford, pp. 91108.